{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:54:41Z","timestamp":1794873281349,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["AIRC IG 26290"],"award-info":[{"award-number":["AIRC IG 26290"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Histone acetylation\/deacetylation play an essential role in modifying chromatin structure and in regulating cell plasticity in eukaryotic cells. Therefore, histone deacetylase (HDAC) pharmacological inhibitors are promising tools in the therapy of fibrotic diseases and in cancer. Peritoneal fibrosis is a pathological process characterized by many cellular and molecular alterations, including the acquisition of invasive\/pro-fibrotic abilities by mesothelial cells (MCs) through induction of mesothelial to mesenchymal transition (MMT). The aim of this study was to characterize the molecular mechanism of the antifibrotic role of HDAC1 inhibition. Specifically, treatment with MS-275, an HDAC1-3 inhibitor previously known to promote MMT reversal, induced the expression of several TGFBRI mRNA-targeting miRNAs. Among them, miR-769-5p ectopic expression was sufficient to promote MMT reversal and to limit MC migration and invasion, whereas miR-769-5p silencing further enhanced mesenchymal gene expression. These results were confirmed by HDAC1 genetic silencing. Interestingly, miR-769-5p silencing maintained mesenchymal features despite HDAC1 inhibition, thus indicating that it is necessary to drive MMT reversal induced by HDAC1 inhibition. Besides TGFBRI, miR-769-5p was demonstrated to target SMAD2\/3 and PAI-1 expression directly. When analyzing molecular mechanisms underlying miR-769-5p expression, we found that the transcription factor Wilms\u2019 tumor 1 (WT1), a master gene controlling MC development, binds to the miR-769-5p promoter favoring its expression. Interestingly, both WT1 expression and binding to miR-769-5p promoter were increased by HDAC1 inhibition and attenuated by TGF\u03b21 treatment. Finally, we explored the significance of these observations in the cell-to-cell communication: we evaluated the ability of miR-769-5p to be loaded into extracellular vesicles (EVs) and to promote MMT reversal in recipient mesenchymal-like MCs. Treatment of fibrotic MCs with EVs isolated from miR-769-5p over-expressing MCs promoted the down-regulation of specific mesenchymal targets and the reacquisition of an epithelial-like morphology. In conclusion, we highlighted an HDAC1-WT1-miR-769-5p axis potentially relevant for therapies aimed at counteracting organ fibrosis.<\/jats:p>","DOI":"10.1038\/s41419-022-05398-0","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T15:05:52Z","timestamp":1668697552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Restoration of WT1\/miR-769-5p axis by HDAC1 inhibition promotes MMT reversal in mesenchymal-like mesothelial cells"],"prefix":"10.1038","volume":"13","author":[{"given":"Giulio","family":"Bontempi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Terri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Garbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Montaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7698-1103","authenticated-orcid":false,"given":"Davide","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Bordoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3097-0003","authenticated-orcid":false,"given":"Clemens","family":"Zwergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9706-848X","authenticated-orcid":false,"given":"Alessandra","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Domenici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Men\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Battistelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6135-971X","authenticated-orcid":false,"given":"Marco","family":"Tripodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3483-8381","authenticated-orcid":false,"given":"Raffaele","family":"Strippoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,17]]},"reference":[{"key":"5398_CR1","doi-asserted-by":"publisher","first-page":"3543678","DOI":"10.1155\/2016\/3543678","volume":"2016","author":"R Strippoli","year":"2016","unstructured":"Strippoli R, Moreno-Vicente R, Battistelli C, Cicchini C, Noce V, Amicone L, et al. Molecular Mechanisms Underlying Peritoneal EMT, and Fibrosis. Stem cells Int. 2016;2016:3543678.","journal-title":"Stem cells Int"},{"key":"5398_CR2","doi-asserted-by":"publisher","first-page":"473134","DOI":"10.1155\/2014\/473134","volume":"2014","author":"M Lopez-Cabrera","year":"2014","unstructured":"Lopez-Cabrera M. Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis. Adv Med. 2014;2014:473134.","journal-title":"Adv Med"},{"key":"5398_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/path.4889","volume":"242","author":"A Rynne-Vidal","year":"2017","unstructured":"Rynne-Vidal A, Au-Yeung CL, Jimenez-Heffernan JA, Perez-Lozano ML, Cremades-Jimeno L, Barcena C, et al. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer. J Pathol. 2017;242:140\u201351.","journal-title":"J Pathol"},{"key":"5398_CR4","doi-asserted-by":"publisher","first-page":"560487","DOI":"10.3389\/fonc.2020.560487","volume":"10","author":"D Wu","year":"2020","unstructured":"Wu D, Qiu Y, Jiao Y, Qiu Z, Liu D. Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy. Front Oncol. 2020;10:560487.","journal-title":"Front Oncol"},{"key":"5398_CR5","doi-asserted-by":"publisher","first-page":"12460","DOI":"10.1021\/acs.jmedchem.0c00830","volume":"63","author":"TCS Ho","year":"2020","unstructured":"Ho TCS, Chan AHY, Ganesan A. Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight. J Med Chem. 2020;63:12460\u201384.","journal-title":"J Med Chem"},{"key":"5398_CR6","doi-asserted-by":"crossref","unstructured":"Di Bello E, Noce B, Fioravanti R, Mai A. Current HDAC Inhibitors in Clinical Trials. Chimia 2022;76:448.","DOI":"10.2533\/chimia.2022.448"},{"key":"5398_CR7","doi-asserted-by":"crossref","unstructured":"Yoon S, Kang G, Eom GH. HDAC Inhibitors: Therapeutic Potential in Fibrosis-Associated Human Diseases. Int J Mol Sci 2019;20;1329.","DOI":"10.3390\/ijms20061329"},{"key":"5398_CR8","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1073\/pnas.96.8.4592","volume":"96","author":"A Saito","year":"1999","unstructured":"Saito A, Yamashita T, Mariko Y, Nosaka Y, Tsuchiya K, Ando T, et al. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc Natl Acad Sci USA. 1999;96:4592\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5398_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26319-2","volume":"8","author":"L Rossi","year":"2018","unstructured":"Rossi L, Battistelli C, de Turris V, Noce V, Zwergel C, Valente S, et al. HDAC1 inhibition by MS-275 in mesothelial cells limits cellular invasion and promotes MMT reversal. Sci Rep. 2018;8:8492.","journal-title":"Sci Rep."},{"key":"5398_CR10","doi-asserted-by":"publisher","first-page":"e54001","DOI":"10.1371\/journal.pone.0054001","volume":"8","author":"N Liu","year":"2013","unstructured":"Liu N, He S, Ma L, Ponnusamy M, Tang J, Tolbert E, et al. Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling. PLoS One. 2013;8:e54001.","journal-title":"PLoS One"},{"key":"5398_CR11","doi-asserted-by":"publisher","first-page":"112132","DOI":"10.1016\/j.biopha.2021.112132","volume":"143","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Abak A, Talebi SF, Shoorei H, Branicki W, Taheri M, et al. Role of miRNA and lncRNAs in organ fibrosis and aging. Biomed Pharmacother. 2021;143:112132.","journal-title":"Biomed Pharmacother"},{"key":"5398_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/089686080602600103","volume":"26","author":"M Lopez-Cabrera","year":"2006","unstructured":"Lopez-Cabrera M, Aguilera A, Aroeira LS, Ramirez-Huesca M, Perez-Lozano ML, Jimenez-Heffernan JA, et al. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure. Perit Dial Int. 2006;26:26\u201334.","journal-title":"Perit Dial Int"},{"key":"5398_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02822-1","volume":"11","author":"R Strippoli","year":"2020","unstructured":"Strippoli R, Sandoval P, Moreno-Vicente R, Rossi L, Battistelli C, Terri M, et al. Caveolin1 and YAP drive mechanically induced mesothelial to mesenchymal transition and fibrosis. Cell Death Dis. 2020;11:647.","journal-title":"Cell Death Dis"},{"key":"5398_CR14","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/S0272-6386(00)70011-4","volume":"35","author":"KN Lai","year":"2000","unstructured":"Lai KN, Lai KB, Lam CW, Chan TM, Li FK, Leung JC. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 2000;35:644\u201352.","journal-title":"Am J Kidney Dis"},{"key":"5398_CR15","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa020809","volume":"348","author":"M Yanez-Mo","year":"2003","unstructured":"Yanez-Mo M, Lara-Pezzi E, Selgas R, Ramirez-Huesca M, Dominguez-Jimenez C, Jimenez-Heffernan JA, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N. Engl J Med. 2003;348:403\u201313.","journal-title":"N. Engl J Med"},{"key":"5398_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/089686089901900306","volume":"19","author":"WS Yang","year":"1999","unstructured":"Yang WS, Kim BS, Lee SK, Park JS, Kim SB. Interleukin-1beta stimulates the production of extracellular matrix in cultured human peritoneal mesothelial cells. Perit Dial Int. 1999;19:211\u201320.","journal-title":"Perit Dial Int"},{"key":"5398_CR17","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/onc.2016.260","volume":"36","author":"C Battistelli","year":"2017","unstructured":"Battistelli C, Cicchini C, Santangelo L, Tramontano A, Grassi L, Gonzalez FJ, et al. The Snail repressor recruits EZH2 to specific genomic sites through the enrollment of the lncRNA HOTAIR in epithelial-to-mesenchymal transition. Oncogene. 2017;36:942\u201355.","journal-title":"Oncogene"},{"key":"5398_CR18","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3389\/fphar.2017.00956","volume":"8","author":"P Magistri","year":"2017","unstructured":"Magistri P, Battistelli C, Strippoli R, Petrucciani N, Pellinen T, Rossi L, et al. SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer. Front Pharm. 2017;8:956.","journal-title":"Front Pharm"},{"key":"5398_CR19","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Thery","year":"2018","unstructured":"Thery C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.","journal-title":"J Extracell Vesicles"},{"key":"5398_CR20","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.celrep.2016.09.031","volume":"17","author":"L Santangelo","year":"2016","unstructured":"Santangelo L, Giurato G, Cicchini C, Montaldo C, Mancone C, Tarallo R, et al. The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting. Cell Rep. 2016;17:799\u2013808.","journal-title":"Cell Rep."},{"key":"5398_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3980","volume":"4","author":"C Villarroya-Beltri","year":"2013","unstructured":"Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, Perez-Hernandez D, Vazquez J, Martin-Cofreces N, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4:2980.","journal-title":"Nat Commun"},{"key":"5398_CR22","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41586-021-04234-3","volume":"601","author":"R Garcia-Martin","year":"2022","unstructured":"Garcia-Martin R, Wang G, Brandao BB, Zanotto TM, Shah S, Kumar Patel S, et al. MicroRNA sequence codes for small extracellular vesicle release and cellular retention. Nature. 2022;601:446\u201351.","journal-title":"Nature"},{"key":"5398_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02257-4","volume":"21","author":"W Liu","year":"2021","unstructured":"Liu W, Wang B, Duan A, Shen K, Zhang Q, Tang X, et al. Exosomal transfer of miR-769-5p promotes osteosarcoma proliferation and metastasis by targeting DUSP16. Cancer Cell Int. 2021;21:541.","journal-title":"Cancer Cell Int"},{"key":"5398_CR24","first-page":"271","volume":"26","author":"K Yanai","year":"2018","unstructured":"Yanai K, Ishii H, Aomatsu A, Ishibashi K, Morishita Y. MicroRNAs in peritoneal fibrosis: a systematic review. Disco Med. 2018;26:271\u201380.","journal-title":"Disco Med"},{"key":"5398_CR25","doi-asserted-by":"publisher","first-page":"110385","DOI":"10.1016\/j.biopha.2020.110385","volume":"129","author":"Y Guo","year":"2020","unstructured":"Guo Y, Wang L, Gou R, Tang L, Liu P. Noncoding RNAs in peritoneal fibrosis: Background, Mechanism, and Therapeutic Approach. Biomed Pharmacother. 2020;129:110385.","journal-title":"Biomed Pharmacother"},{"key":"5398_CR26","doi-asserted-by":"publisher","first-page":"9746","DOI":"10.1002\/jcp.27660","volume":"234","author":"J Shang","year":"2019","unstructured":"Shang J, He Q, Chen Y, Yu D, Sun L, Cheng G, et al. miR-15a-5p suppresses inflammation and fibrosis of peritoneal mesothelial cells induced by peritoneal dialysis via targeting VEGFA. J Cell Physiol. 2019;234:9746\u201355.","journal-title":"J Cell Physiol"},{"key":"5398_CR27","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajpath.2013.05.019","volume":"183","author":"Q Zhou","year":"2013","unstructured":"Zhou Q, Yang M, Lan H, Yu X. miR-30a negatively regulates TGF-beta1-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai1. Am J Pathol. 2013;183:808\u201319.","journal-title":"Am J Pathol"},{"key":"5398_CR28","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.15252\/embr.201540750","volume":"16","author":"M Fierro-Fernandez","year":"2015","unstructured":"Fierro-Fernandez M, Busnadiego O, Sandoval P, Espinosa-Diez C, Blanco-Ruiz E, Rodriguez M, et al. miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2. EMBO Rep. 2015;16:1358\u201377.","journal-title":"EMBO Rep."},{"key":"5398_CR29","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1111\/jcmm.14029","volume":"23","author":"X Li","year":"2019","unstructured":"Li X, Liu H, Sun L, Zhou X, Yuan X, Chen Y, et al. MicroRNA-302c modulates peritoneal dialysis-associated fibrosis by targeting connective tissue growth factor. J Cell Mol Med. 2019;23:2372\u201383.","journal-title":"J Cell Mol Med"},{"key":"5398_CR30","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/labinvest.2014.91","volume":"94","author":"JW Yu","year":"2014","unstructured":"Yu JW, Duan WJ, Huang XR, Meng XM, Yu XQ, Lan HY. MicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis. Lab Invest. 2014;94:978\u201390.","journal-title":"Lab Invest"},{"key":"5398_CR31","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1681\/ASN.2016060663","volume":"28","author":"M Che","year":"2017","unstructured":"Che M, Shi T, Feng S, Li H, Zhang X, Feng N, et al. The MicroRNA-199a\/214 Cluster Targets E-Cadherin and Claudin-2 and Promotes High Glucose-Induced Peritoneal Fibrosis. J Am Soc Nephrol. 2017;28:2459\u201371.","journal-title":"J Am Soc Nephrol"},{"key":"5398_CR32","doi-asserted-by":"publisher","first-page":"15052","DOI":"10.1074\/jbc.RA119.007404","volume":"294","author":"J Wu","year":"2019","unstructured":"Wu J, Huang Q, Li P, Wang Y, Zheng C, Lei X, et al. MicroRNA-145 promotes the epithelial-mesenchymal transition in peritoneal dialysis-associated fibrosis by suppressing fibroblast growth factor 10. J Biol Chem. 2019;294:15052\u201367.","journal-title":"J Biol Chem"},{"key":"5398_CR33","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.ajpath.2017.03.007","volume":"187","author":"M Lopez-Anton","year":"2017","unstructured":"Lopez-Anton M, Lambie M, Lopez-Cabrera M, Schmitt CP, Ruiz-Carpio V, Bartosova M, et al. miR-21 Promotes Fibrogenesis in Peritoneal Dialysis. Am J Pathol. 2017;187:1537\u201350.","journal-title":"Am J Pathol"},{"key":"5398_CR34","doi-asserted-by":"publisher","first-page":"14924","DOI":"10.1073\/pnas.1520329112","volume":"112","author":"P Gasparini","year":"2015","unstructured":"Gasparini P, Cascione L, Landi L, Carasi S, Lovat F, Tibaldi C, et al. microRNA classifiers are powerful diagnostic\/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers. Proc Natl Acad Sci USA. 2015;112:14924\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5398_CR35","doi-asserted-by":"publisher","first-page":"113558","DOI":"10.18632\/oncotarget.23060","volume":"8","author":"Z Yang","year":"2017","unstructured":"Yang Z, He J, Gao P, Niu Y, Zhang J, Wang L, et al. miR-769-5p suppressed cell proliferation, migration and invasion by targeting TGFBR1 in non-small cell lung carcinoma. Oncotarget. 2017;8:113558\u201370.","journal-title":"Oncotarget"},{"key":"5398_CR36","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1016\/j.joca.2013.09.008","volume":"21","author":"JH Wang","year":"2013","unstructured":"Wang JH, Shih KS, Wu YW, Wang AW, Yang CR. Histone deacetylase inhibitors increase microRNA-146a expression and enhance negative regulation of interleukin-1beta signaling in osteoarthritis fibroblast-like synoviocytes. Osteoarthr Cartil. 2013;21:1987\u201396.","journal-title":"Osteoarthr Cartil"},{"key":"5398_CR37","doi-asserted-by":"publisher","first-page":"7572","DOI":"10.18632\/oncotarget.13810","volume":"8","author":"F Abe","year":"2017","unstructured":"Abe F, Kitadate A, Ikeda S, Yamashita J, Nakanishi H, Takahashi N, et al. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma. Oncotarget. 2017;8:7572\u201385.","journal-title":"Oncotarget"},{"key":"5398_CR38","doi-asserted-by":"publisher","first-page":"627","DOI":"10.3389\/fimmu.2015.00627","volume":"6","author":"T Shen","year":"2015","unstructured":"Shen T, Sanchez HN, Zan H, Casali P. Genome-Wide Analysis Reveals Selective Modulation of microRNAs and mRNAs by Histone Deacetylase Inhibitor in B Cells Induced to Undergo Class-Switch DNA Recombination and Plasma Cell Differentiation. Front Immunol. 2015;6:627.","journal-title":"Front Immunol"},{"key":"5398_CR39","first-page":"10","volume":"27","author":"LV Rhodes","year":"2012","unstructured":"Rhodes LV, Nitschke AM, Segar HC, Martin EC, Driver JL, Elliott S, et al. The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells. Oncol Rep. 2012;27:10\u201316.","journal-title":"Oncol Rep."},{"key":"5398_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12931-021-01832-7","volume":"22","author":"F Li","year":"2021","unstructured":"Li F, Wang D, Wang H, Chen L, Sun X, Wan Y. Inhibition of HDAC1 alleviates monocrotaline-induced pulmonary arterial remodeling through up-regulation of miR-34a. Respir Res. 2021;22:239.","journal-title":"Respir Res"},{"key":"5398_CR41","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1158\/0008-5472.CAN-21-0030","volume":"81","author":"J Yang","year":"2021","unstructured":"Yang J, Gao C, Liu M, Liu YC, Kwon J, Qi J, et al. Targeting an Inducible SALL4-Mediated Cancer Vulnerability with Sequential Therapy. Cancer Res. 2021;81:6018\u201328.","journal-title":"Cancer Res"},{"key":"5398_CR42","unstructured":"Tatamiya TSA, Sugawara T, Nakanishi O. Isozyme-selective activity of the HDAC inhibitor MS-275. Experimental and Molecular Therapeutics 23: Histone Deacetylase Inhibitors: American Association for Cancer Research; 2004. p. 567."},{"key":"5398_CR43","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1093\/ndt\/gfr061","volume":"26","author":"T Sakairi","year":"2011","unstructured":"Sakairi T, Abe Y, Kopp JB. TGF-beta1 reduces Wilms\u2019 tumor suppressor gene expression in podocytes. Nephrol Dial Transpl. 2011;26:2746\u201352.","journal-title":"Nephrol Dial Transpl"},{"key":"5398_CR44","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/nep.13411","volume":"24","author":"H Hamatani","year":"2019","unstructured":"Hamatani H, Sakairi T, Ikeuchi H, Kaneko Y, Maeshima A, Nojima Y, et al. TGF-beta1 alters DNA methylation levels in promoter and enhancer regions of the WT1 gene in human podocytes. Nephrol (Carlton). 2019;24:575\u201384.","journal-title":"Nephrol (Carlton)"},{"key":"5398_CR45","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1096\/fj.13-236828","volume":"28","author":"S Karki","year":"2014","unstructured":"Karki S, Surolia R, Hock TD, Guroji P, Zolak JS, Duggal R, et al. Wilms\u2019 tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis. Faseb J. 2014;28:1122\u201331.","journal-title":"Faseb J"},{"key":"5398_CR46","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1016\/j.ajpath.2015.08.009","volume":"185","author":"I Lua","year":"2015","unstructured":"Lua I, Li Y, Pappoe LS, Asahina K. Myofibroblastic Conversion and Regeneration of Mesothelial Cells in Peritoneal and Liver Fibrosis. Am J Pathol. 2015;185:3258\u201373.","journal-title":"Am J Pathol"},{"key":"5398_CR47","doi-asserted-by":"publisher","first-page":"752616","DOI":"10.3389\/fmolb.2021.752616","volume":"8","author":"G Matusali","year":"2021","unstructured":"Matusali G, Trionfetti F, Bordoni V, Nardacci R, Falasca L, Colombo D, et al. Pleural Mesothelial Cells Modulate the Inflammatory\/Profibrotic Response During SARS-CoV-2 Infection. Front Mol Biosci. 2021;8:752616.","journal-title":"Front Mol Biosci"},{"key":"5398_CR48","doi-asserted-by":"crossref","unstructured":"Sontake V, Kasam RK, Sinner D, Korfhagen TR, Reddy GB, White ES, et al. Wilms\u2019 tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease. JCI Insight 2018;3:e121252.","DOI":"10.1172\/jci.insight.121252"},{"key":"5398_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12701-9","volume":"10","author":"TJ Kendall","year":"2019","unstructured":"Kendall TJ, Duff CM, Boulter L, Wilson DH, Freyer E, Aitken S, et al. Embryonic mesothelial-derived hepatic lineage of quiescent and heterogenous scar-orchestrating cells defined but suppressed by WT1. Nat Commun. 2019;10:4688.","journal-title":"Nat Commun"},{"key":"5398_CR50","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1002\/hep.24280","volume":"53","author":"L Santangelo","year":"2011","unstructured":"Santangelo L, Marchetti A, Cicchini C, Conigliaro A, Conti B, Mancone C, et al. The stable repression of mesenchymal program is required for hepatocyte identity: a novel role for hepatocyte nuclear factor 4alpha. Hepatology. 2011;53:2063\u201374.","journal-title":"Hepatology"},{"key":"5398_CR51","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1074\/jbc.M115.678029","volume":"291","author":"MM Akpa","year":"2016","unstructured":"Akpa MM, Iglesias D, Chu L, Thiebaut A, Jentoft I, Hammond L, et al. Wilms Tumor Suppressor, WT1, Cooperates with MicroRNA-26a and MicroRNA-101 to Suppress Translation of the Polycomb Protein, EZH2, in Mesenchymal Stem Cells. J Biol Chem. 2016;291:3785\u201395.","journal-title":"J Biol Chem"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05398-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05398-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05398-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:03:37Z","timestamp":1668816217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05398-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,17]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["5398"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05398-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,17]]},"assertion":[{"value":"1 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"965"}}